DavidAndrewLipsonMD
Pulmonology • Philadelphia, PAAsthma & COPD, Critical Care Medicine, Cystic Fibrosis, Pleural Disease
Physician
Dr. Lipson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Spruce Street
Philadelphia, PA 19104Phone+1 215-662-3202- Is this information wrong?
Summary
- Dr. David Lipson is a pulmonologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Penn Presbyterian Medical Center and Hospital of the University of Pennsylvania. He received his medical degree from Sidney Kimmel Medical College and has been in practice 23 years. He specializes in COPD, CF, and bronchiectasis and is experienced in critical care medicine. He also serves as the Respiratory Disease Area Lead in Development Clinical Sciences overseeing all late phase respiratory clinical trials at GlaxoSmithKline.
Education & Training
University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1997 - 2000- University of Pennsylvania Health SystemResidency, Internal Medicine, 1995 - 1997
- University of Pennsylvania Health SystemInternship, Internal Medicine, 1994 - 1995
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1994
Certifications & Licensure
PA State Medical License 1995 - 2024- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Fellow of the American College of Chest Physicians (FCCP) American College of Chest Physicians
Publications & Presentations
PubMed
- 4 citationsMortality Risk and Serious Cardiopulmonary Events in Moderate-to-Severe COPD: Post Hoc Analysis of the IMPACT Trial.J Michael Wells, Gerard J Criner, David M G Halpin, MeiLan K Han, Renu Jain, Peter Lange, David A Lipson, Fernando J Martinez, Dawn Midwinter, Dave Singh, Robert A Wise> ;Chronic Obstructive Pulmonary Diseases. 2023 Jan 25
- 1 citationsSingle-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis.Samuel Bardsley, Gerard J Criner, David M G Halpin, MeiLan K Han, Nicola A Hanania, David Hill, Peter Lange, David A Lipson, Fernando J Martinez, Dawn Midwinter, Thoma...> ;Respiratory Medicine. 2022 Dec 1
- 7 citationsInternational Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials.Peter M A Calverley, Fernando J Martinez, Jørgen Vestbo, Christine R Jenkins, Robert Wise, David A Lipson, Nicholas J Cowans, Julie Yates, Courtney Crim, Bartolome R C...> ;American Journal of Respiratory and Critical Care Medicine. 2022 Jul 1
- Join now to see all
Press Mentions
Measuring Disease Activity in COPD: Is Clinically Important Deterioration the Answer?June 2nd, 2020
Grant Support
- V &Q Disturbances In Obliterative BronchiolitisNational Heart, Lung, And Blood Institute2001–2005
Hospital Affiliations
Penn Presbyterian Medical CenterPhiladelphia, Pennsylvania- Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
